SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-05-002275
Filing Date
2005-01-21
Accepted
2005-01-21 17:21:11
Documents
3
Period of Report
2005-01-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a05-2116_18k.htm 8-K 33815
2 EX-1.1 a05-2116_1ex1d1.htm EX-1.1 202366
3 EX-5.1 a05-2116_1ex5d1.htm EX-5.1 22994
  Complete submission text file 0001104659-05-002275.txt   261085
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19700 | Film No.: 05542429
SIC: 2834 Pharmaceutical Preparations